P1558: PROPHYLAXIS WITH TIXAGEVIMAB-CILGAVIMAB IN SINGLE-CENTER EXPERIENCE CAN REDUCE SEVERE COMPLICATIONS RELATED TO SARS-COV-2 INFECTION IN HEMATOLOGICAL PATIENTS

Detalles Bibliográficos
Autores principales: Duminuco, Andrea, Nardo, Antonella, Orofino, Alessandra, Romano, Alessandra, Figuera, Amalia Stefania, Chiarenza, Annalisa, Markovic, Uros, Caruso, Laura, Giunta, Giuliana, Leotta, Salvatore, Milone, Giuseppe, Cupri, Alessandra, Conticello, Concetta, Fabro, Vittorio Del, Mauro, Elisa, Maugeri, Cinzia, Vetro, Calogero, Parisi, Marina, Raimondo, Francesco DI, Palumbo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430325/
http://dx.doi.org/10.1097/01.HS9.0000973108.49863.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430325/
http://dx.doi.org/10.1097/01.HS9.0000973108.49863.33

Ejemplares similares